{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:26:44Z","timestamp":1776115604436,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS023011"],"award-info":[{"award-number":["K12 HS023011"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaad.2022.04.061","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:18:39Z","timestamp":1652138319000},"page":"582-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Longitudinal course and predictors of depressive symptoms in atopic dermatitis"],"prefix":"10.1016","volume":"87","author":[{"given":"Sheena","family":"Chatrath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10247","key":"10.1016\/j.jaad.2022.04.061_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.061_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.061_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaad.2018.08.063","article-title":"Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis","volume":"80","author":"Patel","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.061_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamadermatol.2018.4566","article-title":"Association between atopic dermatitis and suicidality: a systematic review and meta-analysis","volume":"155","author":"Sandhu","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the National Eczema Association","volume":"137","author":"Drucker","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.061_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.jaad.2022.04.061_bib7","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/jid.2015.337","article-title":"Association between atopic dermatitis and depression in US adults","volume":"135","author":"Yu","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaad.2022.04.061_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bjd.18657","article-title":"Validation of five patient-reported outcomes for atopic dermatitis severity in adults","volume":"182","author":"Silverberg","year":"2020","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2022.04.061_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00403-021-02185-3","article-title":"Validity and reliability of a novel numeric rating scale to measure skin-pain in adults with atopic dermatitis","volume":"313","author":"Silverberg","year":"2021","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.061_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/bjd.15179","article-title":"Patient-oriented eczema measure (POEM), a core instrument to measure symptoms in clinical trials: a harmonising outcome measures for eczema (HOME) statement","volume":"176","author":"Spuls","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.061_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/DER.0000000000000653","article-title":"Measurement properties of patient health questionnaire 9 and patient health questionnaire 2 in adult patients with atopic dermatitis","volume":"32","author":"Silverberg","year":"2021","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.061_bib13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bjd.15641","article-title":"Severity strata for eczema area and severity index (EASI), modified EASI, scoring atopic dermatitis (SCORAD), objective SCORAD, atopic dermatitis severity index and body surface area in adolescents and adults with atopic dermatitis","volume":"177","author":"Chopra","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.061_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clindermatol.2018.05.012","article-title":"Assessing the severity of atopic dermatitis in clinical trials and practice","volume":"36","author":"Chopra","year":"2018","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.04.061_bib15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2017.04.052","article-title":"Relationship between EASI and SCORAD severity assessments for atopic dermatitis","volume":"140","author":"Chopra","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.061_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Chiesa Fuxench","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.061_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2005.07050.x","article-title":"Life quality assessment among patients with atopic eczema","volume":"154","author":"Holm","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/DER.0000000000000418","article-title":"Atopic dermatitis and hospitalization for mental health disorders in the United States","volume":"30","author":"Hsu","year":"2019","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.061_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.apnu.2017.06.001","article-title":"Health-related quality of life and mental health of adults with atopic dermatitis","volume":"31","author":"Kwak","year":"2017","journal-title":"Arch Psychiatr Nurs"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.061_bib21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s12325-021-01630-z","article-title":"Psychosocial comorbidities and health status among adults with moderate-to-severe atopic dermatitis: a 2017 US National Health and Wellness Survey analysis","volume":"38","author":"Kwatra","year":"2021","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.061_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjd.17683","article-title":"Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults","volume":"181","author":"Silverberg","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.061_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2019.06.002","article-title":"Depression and psychological distress in US adults with atopic dermatitis","volume":"123","author":"Cheng","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1S","key":"10.1016\/j.jaad.2022.04.061_bib24","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/DER.0000000000000687","article-title":"High levels of psychological distress, sleep disturbance, and alcohol use disorder in adults with atopic dermatitis","volume":"32","author":"Gilhooley","year":"2021","journal-title":"Dermatitis"},{"issue":"9","key":"10.1016\/j.jaad.2022.04.061_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jaad.2022.04.061_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.genhosppsych.2016.06.006","article-title":"Suicidal ideation in persons with neurological conditions: prevalence, associations and validation of the PHQ-9 for suicidal ideation","volume":"42","author":"Altura","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.061_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1370\/afm.1139","article-title":"Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population","volume":"8","author":"Arroll","year":"2010","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jaad.2022.04.061_bib28","doi-asserted-by":"crossref","first-page":"110487","DOI":"10.1016\/j.jpsychores.2021.110487","article-title":"Validation of the PHQ-9 in adults with dissociative seizures","volume":"146","author":"Lopez","year":"2021","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.061_bib29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ageing\/aft065","article-title":"Validation and internal consistency of patient health questionnaire-9 for major depression in Parkinson\u2019s disease","volume":"42","author":"Chagas","year":"2013","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12888-020-02699-6","article-title":"The validity and reliability of the PHQ-9 in screening for post-stroke depression","volume":"20","author":"Dajpratham","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"1-3","key":"10.1016\/j.jaad.2022.04.061_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2011.06.017","article-title":"How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires","volume":"134","author":"Delgadillo","year":"2011","journal-title":"J Affect Disord"},{"issue":"8","key":"10.1016\/j.jaad.2022.04.061_bib32","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/ibd\/izy032","article-title":"Validation of the PHQ-9 for suicidal ideation in persons with inflammatory bowel disease","volume":"24","author":"Litster","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"23","key":"10.1016\/j.jaad.2022.04.061_bib33","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/BRS.0000000000003644","article-title":"A validation of patient health questionnaire-9 for cervical spine surgery","volume":"45","author":"Parrish","year":"2020","journal-title":"Spine"},{"key":"10.1016\/j.jaad.2022.04.061_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yebeh.2014.06.030","article-title":"Validation of the patient health questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy","volume":"37","author":"Rathore","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jaad.2022.04.061_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s10194-015-0552-2","article-title":"Validation of the patient health questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine","volume":"16","author":"Seo","year":"2015","journal-title":"J Headache Pain"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.061_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00737-012-0295-x","article-title":"Validation of the patient health questionnaire (PHQ)-9 for prenatal depression screening","volume":"15","author":"Sidebottom","year":"2012","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.jaad.2022.04.061_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1472-6963-10-235","article-title":"Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics","volume":"10","author":"van Steenbergen-Weijenburg","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.061_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10926-015-9607-0","article-title":"Validation of the patient health questionnaire-9 for major depressive disorder in the occupational health setting","volume":"26","author":"Volker","year":"2016","journal-title":"J Occup Rehabil"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12888-020-02885-6","article-title":"The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital","volume":"20","author":"Sun","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12978-019-0802-x","article-title":"The reliability and validity of the patient health questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility","volume":"16","author":"Maroufizadeh","year":"2019","journal-title":"Reprod Health"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the scorad index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.061_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2133.2004.05696.x","article-title":"Validation of the eczema area and severity index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme","volume":"150","author":"Barbier","year":"2004","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222007927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222007927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:38Z","timestamp":1759273418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222007927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0190962222007927"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.061","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal course and predictors of depressive symptoms in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}